內容大鋼
《循證皮膚病學（第2版英文原版）精）》由霍華德·I.梅巴克主編。
Evidence-based thinking in clinical medicine has had a great impact on the physician's approach to clinical care. In addition to promoting the understanding of the evidence-based philosophy, the authors have focused on some of the fundamentals in dermatology that need to be approached differently. Issues such as the interpretation of clinical research, disease-oriented evidence versus patient-care evidence, and the use of placebo are examined. Evidence-based patient care in dermatology is a growing area in dermatology, and this work presents the ideology and methodology of critical thinking that includes the available evidence across the field. Evidence Based Dermatology is aimed at both primary care physicians and dormatologists, encouraging disease management decisions to be based on the highest level of evidence. Authored by world renewed authors in Dermatology and incorporating a text with all new four color design and images;this new edition explores disease mechanisms and treatments in greater depth and detail in order to providemore insight for the reader.
New four color design
New four color images
Completely revised with many new chapters by Leading Opinion leaders from around the world in Dermatology
目錄
PART I Diagnosis
CHAPTER 1 Studies and Systematic Reviews on Diagnostic Test Accuracy
CHAPTER 2 Diagnostic Accuracy of Teledermatology
CHAPTER 3 Evidence-Based Patch Testing
CHAPTER 4 Diagnosis of Melanoma
CHAPTER 5 Diagnosis of Cutaneous T-Cell Lymphoma
CHAPTER 6 Diagnostic Criteria for Cutaneous Lupus Erythematosus
CHAPTER 7 Diagnosis of Parasitic Skin Diseases
CHAPTER 8 Diagnosis of Hirsutism
PART II Therapy
CHAPTER 9 Systematic Review and Meta-Analysis
CHAPTER 10 Treatment of Hand Dermatitis
CHAPTER 11 Treatment of Acute Urticaria and Angioedema
CHAPTER 12 Treatment of Chronic Urticaria
CHAPTER 13 Atopic Dermatitis
CHAPTER 14 Treatment of Melasma
CHAPTER 15 Treatment of Psoriasis
CHAPTER 16 Treatment of Lichen Planus
……
PART III Risk Factor Analysis
PART IV Pharmacoepidemiology
PART V Cost Effectiveness Studies
PART VI Evidence Based Approach
Index
[